GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS
GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS
批准号:
6897752
负责人:
ROBERT PAUL FRIEDLAND
金额:
$15.3万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2005-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): In a population based
study of AD, we have screened all elderly residents of Wadi Ara, an Arab
community near Tel Aviv in northern Israel, and observed an unusually high
prevalence (20.5% of those >60 years, 60.5% of those >85 years). This
prevalence is higher than that found anywhere else in the world, even after
adjustment for age, education and gender, and apparently is not due to
increased frequency of the APOE epsilon-4 allele. We hypothesize that the
increased prevalence of AD in this genetic isolate is caused by the presence of
AD susceptibility alleles which are over-represented because of mating patterns
in this closed population which has few founders. In this application we
propose to study extensively all persons residing in this community ages 60 and
older (numbering 855 at the time of the last survey including 168 persons
meeting NINDS/ADRDA criteria for AD). We will obtain from each subject
risk/protective factor data (including smoking, blood pressure, head trauma,
education, diet, physical and mental activity levels, occupation and medication
history) and blood samples for biochemical and DNA studies. Family informants
will be used to construct detailed pedigrees. Our scientific aims are: (1)
Estimate the life-time risk of AD in first-degree relatives of prevalent cases
using survival techniques and compare these estimates to those obtained for
relatives of cognitively normal subjects and for relatives of AD cases in other
populations; (2) Localize the gene(s) causing AD in this population using a
homozygosity mapping approach. In order to rapidly screen for markers linked to
the disease, one AD affected and one elderly nondemented from each of several
families from the same tribal group (hamula) will be genotyped with 400
polymorphic microsatellite markers spaced less than 10 cM apart. Suspect
chromosomal regions will be pursued by genotyping all subjects individually
with markers spaced at 2 cM intervals. A variety of analytical techniques
including both parametric (lod score) and non-parametric (affected relative,
sib-transmission-disequilibrium and allele-frequency-dependent homozygosity
mapping) approaches will be employed to assess the marker data for linkage to
AD; (3) Examine genes from candidate regions identified in aim 2 by SSCP/CSGE;
and direct sequencing for polymorphisms which may directly influence AD
susceptibility; (4) Analyze the effects of non-genetic factors (singly and in
combination with each other and with linked genetic markers or candidate gene
polymorphisms) on risk of AD.
Identifying specific genes and elucidating their mechanisms and the nature of
gene/environment interactions will be a major achievement. Results from this
study may have immediate impact on the development of new treatment or
prevention strategies.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel.
居住在以色列的阿拉伯人中阿尔茨海默病的遗传和环境流行病学。
DOI:
10.1385/jmn:20:3:207
发表时间:
2003
期刊:
Journal of molecular neuroscience : MN
影响因子:
--
作者:
[Farrer,LindsayA, Friedland,RobertP, Bowirrat,Abdalla, Waraska,Kristin, Korczyn,Amos, Baldwin,ClintonT]
通讯作者:
Baldwin,ClintonT
DOI:
10.3389/fneur.2012.00136
发表时间:
2012
期刊:
Frontiers in neurology
影响因子:
3.4
作者:
[Friedland RP, Shah JJ, Farrer LA, Vardarajan B, Rebolledo-Mendez JD, Mok K, Hardy J]
通讯作者:
Hardy J
DOI:
10.1371/journal.pone.0060621
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Liu R, Vaishnav RA, Roberts AM, Friedland RP]
通讯作者:
Friedland RP
DOI:
--
发表时间:
2002-08
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
[Jiong Shi;George Perry;M. Berridge;G. Aliev;S. Siedlak;Mark A. Smith;J. LaManna;R. Friedland]
通讯作者:
Jiong Shi;George Perry;M. Berridge;G. Aliev;S. Siedlak;Mark A. Smith;J. LaManna;R. Friedland
Cong Intl. Soc Vascular Behavioral & Cognitive Disorders
-
批准号:6998162
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2005
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
Symposium on Alzheimer's Disease in the Middle East
-
批准号:6998344
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2005
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
International Society for Vascular Behavioral Disorders
-
批准号:6667869
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2003
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
Symposium on Alzheimer's Disease in the Middle East
-
批准号:6615404
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2003
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
First International Symposium on Alzheimer's Disease
-
批准号:6318452
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2001
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS
-
批准号:6128678
-
项目类别:
-
资助金额:$48.8万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
Genetics of Alzheimer's Disease in Israeli Arabs
-
批准号:7111086
-
项目类别:
-
资助金额:$106.88万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
Genetics of Alzheimer's Disease in Israeli Arabs
-
批准号:6918787
-
项目类别:
-
资助金额:$113.56万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS
-
批准号:6372396
-
项目类别:
-
资助金额:$50.57万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS
-
批准号:6799873
-
项目类别:
-
资助金额:$5.98万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
Genetics of Alzheimer's Disease in Israeli Arabs
-
批准号:7653706
-
项目类别:
-
资助金额:$107.84万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
Genetics of Alzheimer's Disease in Israeli Arabs
-
批准号:7479207
-
项目类别:
-
资助金额:$106.32万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
GENETICS OF ALZHEIMER'S DISEASE IN ISRAELI ARABS
-
批准号:6533832
-
项目类别:
-
资助金额:$51.94万
-
财政年份:2000
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:6218697
-
项目类别:
-
资助金额:$10.24万
-
财政年份:1999
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:6295466
-
项目类别:
-
资助金额:$10.24万
-
财政年份:1999
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:6098156
-
项目类别:
-
资助金额:$10.24万
-
财政年份:1999
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:6267403
-
项目类别:
-
资助金额:$13.91万
-
财政年份:1998
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:6295480
-
项目类别:
-
资助金额:$10.24万
-
财政年份:1998
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:6234167
-
项目类别:
-
资助金额:$12.89万
-
财政年份:1997
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:
CORE--CLINICAL
-
批准号:5204574
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT PAUL FRIEDLAND
-
依托单位:--
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: